Asset Details
Do you wish to reserve the book?
Aggregate travel vs. single trip assessment: Arguments for cumulative risk analysis
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Aggregate travel vs. single trip assessment: Arguments for cumulative risk analysis
Do you wish to request the book?
Aggregate travel vs. single trip assessment: Arguments for cumulative risk analysis
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Aggregate travel vs. single trip assessment: Arguments for cumulative risk analysis
2012
Overview
► Frequent travel for work or leisure is common. ► Vaccine decisions are traditionally based on individual trip risk analysis. ► Many pre-travel vaccines can be considered an investment as they provide long-term protection. ► Vaccine recommendations should formally consider cumulative risks from future trips.
Vaccine recommendations for travellers are based on individual risk assessments of multiple factors, most importantly the destination and duration of the impending trip. Many people undertake frequent trips, but existing WHO, CDC and national advisory board recommendations do not explicitly consider cumulative travel-associated risks. Given the period of protection provided by many vaccines, in particular rabies, hepatitis A, hepatitis B and yellow fever vaccines, an aggregate multi-trip risk assessment which views vaccines as an investment for future travel health may be more appropriate than separately evaluating the risks for each trip.
Publisher
Elsevier Ltd,Elsevier Limited
Subject
